Evidence map›Paper›PMID 36768978›Full record

ReviewInternational journal of molecular sciences2023

Phytochemicals as Immunomodulatory Agents in Melanoma.

Claudio Tabolacci, Daniela De Vita, Antonio Facchiano, Giuseppina Bozzuto, Simone Beninati, Cristina Maria Failla, Marta Di Martile, Carla Lintas, Carlo Mischiati, Annarita Stringaro and 2 more

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Natural Sunlight-Mediated Emodin Photoinactivation ofInternational journal of molecular sciences · 2024
    Article
  9. Immunomodulation of Skin Cancer.International journal of molecular sciences · 2023
    Article
  10. International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Claudio TabolacciDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.ORCID 0000-0001-5001-285X
Daniela De VitaDepartment of Environmental Biology, University of Rome La Sapienza, 00185 Rome, Italy.
Antonio FacchianoLaboratory of Molecular Oncology, IDI-IRCCS, 00167 Rome, Italy.ORCID 0000-0002-4243-2392
Giuseppina BozzutoNational Center for Drug Research and Evaluation, Istituto Superiore di Sanità, 00161 Rome, Italy.
Simone BeninatiDepartment of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.ORCID 0000-0002-2704-0745
Cristina Maria FaillaExperimental Immunology Laboratory, IDI-IRCCS, 00167 Rome, Italy.ORCID 0000-0001-5991-8914
Marta Di MartilePreclinical Models and New Therapeutic Agents Unit, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.ORCID 0000-0001-9924-9022
Carla LintasResearch Unit of Medical Genetics, Department of Medicine, Università Campus Bio-Medico, 00128 Rome, Italy.ORCID 0000-0003-1209-8554
Carlo MischiatiDepartment of Neuroscience and Rehabilitation, School of Medicine, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0002-0029-2205
Annarita StringaroNational Center for Drug Research and Evaluation, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0002-0143-2978
Donatella Del BufaloPreclinical Models and New Therapeutic Agents Unit, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Francesco FacchianoDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.ORCID 0000-0003-4313-0617

Funding

Bank of Italy Contributo Liberale from Banca d'ItaliaItalian Association for Cancer Research IG 2020 (Id 24315)Ministero della Salute RF-2019-12369805
6 · The paper itself

Abstract

Cutaneous melanoma is an immunogenic highly heterogenic tumor characterized by poor outcomes when it is diagnosed late. Therefore, immunotherapy in combination with other anti-proliferative approaches is among the most effective weapons to control its growth and metastatic dissemination. Recently, a large amount of published reports indicate the interest of researchers and clinicians about plant secondary metabolites as potentially useful therapeutic tools due to their lower presence of side effects coupled with their high potency and efficacy. Published evidence was reported in most cases through in vitro studies but also, with a growing body of evidence, through in vivo investigations. Our aim was, therefore, to review the published studies focused on the most interesting phytochemicals whose immunomodulatory activities and/or mechanisms of actions were demonstrated and applied to melanoma models.

Indexed as

MelanomaSkin NeoplasmsImmunomodulating AgentsPhytochemicalsPlantsImmunomodulating AgentsPhytochemicalscytokynesimmunomodulationinflammationmelanomaphytochemicalsplant secondary metabolites

Identifiers

PMID36768978
PMCPMC9916941

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.